Related references
Note: Only part of the references are listed.STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma
Katharina L. Kopp et al.
CELL CYCLE (2013)
Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts
Carolyn S. Lee et al.
BLOOD (2012)
Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma
Elodie Begue et al.
BLOOD (2012)
Increased Twist expression in advanced stage of mycosis fungoides and Sezary syndrome
Meghali Goswami et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2012)
Molecular Markers of Early-Stage Mycosis Fungoides
Yaohua Zhang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Regulation of T-Plastin Expression by Promoter Hypomethylation in Primary Cutaneous T-Cell Lymphoma
Christine L. Jones et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
A Meta-Analysis of Gene Expression Data Identifies a Molecular Signature Characteristic for Tumor-Stage Mycosis Fungoides
Marloes S. van Kester et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient
Chengcheng Gao et al.
MEDICAL ONCOLOGY (2012)
miR-122 Regulates p53/Akt Signalling and the Chemotherapy-Induced Apoptosis in Cutaneous T-Cell Lymphoma
Valentina Manfe et al.
PLOS ONE (2012)
Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription
Yang Wang et al.
BLOOD (2011)
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)
Ulrik Ralfkiaer et al.
BLOOD (2011)
Chronic inflammation and immunologic-based constraints in malignant disease
Devin B. Lowe et al.
IMMUNOTHERAPY (2011)
Malignant Cutaneous T-Cell Lymphoma Cells Express IL-17 Utilizing the Jak3/Stat3 Signaling Pathway
Thorbjorn Krejsgaard et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
MicroRNA-21 Expression in CD4+T Cells Is Regulated by STAT3 and Is Pathologically Involved in Sezary Syndrome
Leslie van der Fits et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
miRNA expression profiling of mycosis fungoides
Marloes S. van Kester et al.
MOLECULAR ONCOLOGY (2011)
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome
M. G. Narducci et al.
CELL DEATH & DISEASE (2011)
MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential
Erica Ballabio et al.
BLOOD (2010)
Novel approach to gene expression profiling in Sezary syndrome
R. G. Pomerantz et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Activation of EphA receptors on CD4+CD45RO+ memory cells stimulates migration
H. L. Holen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome
Remco van Doorn et al.
BLOOD (2009)
Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy
Liuyan Jiang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Lack of T-Cell Receptor-Induced Signaling Is Crucial for CD95 Ligand Up-regulation and Protects Cutaneous T-Cell Lymphoma Cells from Activation-Induced Cell Death
Claus-Detlev Klemke et al.
CANCER RESEARCH (2009)
Low FAS/CD95 Expression by CTCL Correlates with Reduced Sensitivity to Apoptosis that Can Be Restored by FAS Upregulation
Jianqiang Wu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
Novel and highly recurrent chromosomal alterations in Sezary syndrome
Maarten H. Vermeer et al.
CANCER RESEARCH (2008)
A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS
Xin Mao et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2008)
Development of all CD4 T lineages requires nuclear factor TOX
Parinaz Aliahmad et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Induction of T-Cell Responses against Cutaneous T-Cell Lymphomas Ex Vivo by Autologous Dendritic Cells Transfected with Amplified Tumor mRNA
Xiao Ni et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3
N. Booken et al.
LEUKEMIA (2008)
Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome
Jessica Shin et al.
BLOOD (2007)
Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma
Sonja Hahtola et al.
CLINICAL CANCER RESEARCH (2006)
Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy
M Nebozhyn et al.
BLOOD (2006)
Down-regulating constitutive activation of the NF-κB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis
A Sors et al.
BLOOD (2006)
Absence of CD26 expression on skin-homing CLA+CD4+T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sezary syndrome
M Sokolowska-Wojdylo et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2005)
A conserved noncoding intronic transcript at the mouse Dnm3 locus
DAF Loebel et al.
GENOMICS (2005)
Actin-filament cross-linking protein T-plastin increases Arp2/3-mediated actin-based movement
A Giganti et al.
JOURNAL OF CELL SCIENCE (2005)
NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-ß (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor
G Kuratomi et al.
BIOCHEMICAL JOURNAL (2005)
CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells:: Relevance for the diagnosis and follow-up of Sezary syndrome
E Poszepczynska-Guigné et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Immune surveillance in the skin: Mechanisms and clinical consequences
TS Kupper et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers
C Hafner et al.
CLINICAL CHEMISTRY (2004)
BCL2 and JUNB abnormalities in primary cutaneous lymphomas
X Mao et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
TRANCE counteracts FasL-mediated apoptosis of murine bone marrow-derived dendritic cells
AS Chen et al.
CELLULAR IMMUNOLOGY (2004)
Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis
R van Doorn et al.
CANCER RESEARCH (2004)
In vivo activation of STAT3 in cutaneous T-cell lymphoma.: Evidence for an antiapoptotic function of STAT3
VH Sommer et al.
LEUKEMIA (2004)
c-Maf and JunB mediation of Th2 differentiation induced by the type 2 G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide
J Voice et al.
JOURNAL OF IMMUNOLOGY (2004)
Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway:: an expression profile study
L Tracey et al.
BLOOD (2003)
Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression
YH Kim et al.
ARCHIVES OF DERMATOLOGY (2003)
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma
L Kari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Bcl11a is essential for normal lymphoid development
PT Liu et al.
NATURE IMMUNOLOGY (2003)
Dynamin at the actin-membrane interface
JD Orth et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
Expression of the murine CD27 ligand CD70 in vitro and in vivo
K Tesselaar et al.
JOURNAL OF IMMUNOLOGY (2003)
Src family kinases in tumor progression and metastasis
JM Summy et al.
CANCER AND METASTASIS REVIEWS (2003)
Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions
K Tesselaar et al.
NATURE IMMUNOLOGY (2003)
Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB
B Hartenstein et al.
EMBO JOURNAL (2002)
Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12Rβ2 chain expression and signaling
R Nishikomori et al.
JOURNAL OF IMMUNOLOGY (2002)
The BCL2 family: Regulators of the cellular life-or-death switch
S Cory et al.
NATURE REVIEWS CANCER (2002)
Defective T cell development and function in calcineurin Aβ-deficient mice
OF Bueno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Transforming growth factor-beta in T-cell biology
L Gorelik et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Constitutive STAT3-activation in Sezary syndrome:: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells
KW Eriksen et al.
LEUKEMIA (2001)
Versican interacts with chemokines and modulates cellular responses
J Hirose et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy
S Osella-Abate et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL
O Zoi-Toli et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo
R Josien et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)